Results 21 to 30 of about 69,642 (298)

Yellow fever vaccine [PDF]

Human Vaccines & Immunotherapeutics, 2013
Yellow fever (YF) is an acute viral communicable disease transmitted by an arbovirus of the Flavivirus genus. It is primarily a zoonotic disease, especially the monkeys. Worldwide, an estimated 200,000 cases of yellow fever occurred each year, and the case-fatality rate is ~15%.
Mark D. Gershman, J. Erin Staples, Thomas P. Monath, Alan D.T. Barrett   +3 more
openaire   +5 more sources

Yellow fever vaccination before and during the covid-19 pandemic in Brazil

Revista de Saúde Pública, 2022
OBJECTIVE To analyze the number of yellow fever vaccine doses administered before and during the covid-19 pandemic in Brazil. METHODS This is an ecological, time series study based on data from the National Immunization Program.
Tércia Moreira Ribeiro da Silva, Ana Carolina Micheletti Gomide Nogueira de Sá, Elton Junio Sady Prates, Daiana Elias Rodrigues, Thales Philipe Rodrigues da Silva, Fernanda Penido Matozinhos, Ed Wilson Rodrigues Vieira   +6 more
doaj   +1 more source

Characterization of Yellow Fever Suspected Cases and Confirmed Outbreaks in a Southwest State, Nigeria, 2021 [PDF]

Journal of Health Sciences and Surveillance System, 2022
Background: Yellow fever (YF) is an acute viral hemorrhagic fever caused by the yellow fever virus and transmitted by Aedes mosquito species. Despite the availability of a very effective vaccine, yellow fever virus (YFV) remains a public health threat ...
Itse Olaoye, Akinola Fatiregun, Adewale M. Adejugbagbe, Modupeola Dosumu, Ekun Opeyemi, Zubairu Mahmud, David Adeleke, Tsemaye Jacdonmi, Aladesawe Adesokeji, Famokun Gboyega, Abiona Samuel   +10 more
doaj   +1 more source

Re-thinking yellow fever vaccines: fighting old foes with new generation vaccines

Human Vaccines & Immunotherapeutics, 2022
Despite the existence of a highly efficient yellow fever vaccine, yellow fever reemergence throughout Africa and the Americas has put 900 million people in 47 countries at risk of contracting the disease.
Gerardo Montalvo Zurbia-Flores, Christine S Rollier, Arturo Reyes-Sandoval   +2 more
doaj   +1 more source

The Present and Future of Yellow Fever Vaccines [PDF]

Pharmaceuticals, 2021
The disease yellow fever (YF) is prevented by a live-attenuated vaccine, termed 17D, which has been in use since the 1930s. One dose of the vaccine is thought to give lifelong (35+ years) protective immunity, and neutralizing antibodies are the correlate of protection. Despite being a vaccine-preventable disease, YF remains a major public health burden,
Clairissa A. Hansen, Alan D. T. Barrett
openaire   +3 more sources

The local health impacts of natural resource booms

Health Economics, Volume 32, Issue 2, Page 462-500, February 2023., 2023
Abstract This paper uses novel micro‐data on natural resources and administrative health data in Brazil to study how economic booms in minerals affect health at birth. By implementing a reduced‐form estimation of shift‐share research designs, the identification strategy relies on the exogeneity of global commodity prices to municipality‐specific health
Elisa M. Maffioli
wiley   +1 more source

Insect‐specific viruses used in biocontrol of mosquito‐borne diseases

Interdisciplinary Medicine, Volume 1, Issue 1, January 2023., 2023
Insect‐specific RNA viruses (ISRVs) are involved in a wide range of families including Flaviviridae, Bunyaviridae, Negeviruses, Togaviridae, Reoviridae, Mesoniviridae, and Rhabdoviridae, which cannot infect vertebrates, including humans. However, ISRVs can infect and replicate in mosquitoes, interfering with the replication of mosquito‐borne viruses ...
Jiating Chen, Shengqun Deng, Hongjuan Peng   +2 more
wiley   +1 more source

Yellow Fever outbreaks in unvaccinated populations, Brazil, 2008-2009. [PDF]

PLoS Neglected Tropical Diseases, 2014
Due to the risk of severe vaccine-associated adverse events, yellow fever vaccination in Brazil is only recommended in areas considered at risk for disease.
Alessandro Pecego Martins Romano, Zouraide Guerra Antunes Costa, Daniel Garkauskas Ramos, Maria Auxiliadora Andrade, Valéria de Sá Jayme, Marco Antônio Barreto de Almeida, Kátia Campomar Vettorello, Melissa Mascheretti, Brendan Flannery   +8 more
doaj   +1 more source

Science with society: Challenges of early‐stage researchers engaging with transdisciplinary research in sustainability science

Sustainable Development, Volume 30, Issue 6, Page 1562-1572, December 2022., 2022
Abstract The ongoing social and ecological crises create urgency in academia and elsewhere to devise actionable problem‐solving knowledge to tackle sustainability challenges. Transdisciplinary research (TDR) represents a problem‐solving methodology for sustainability problems.
Kaustubh Thapa, Walter J. V. Vermeulen, Pauline Deutz   +2 more
wiley   +1 more source

Progress in COVID research and developments during pandemic

VIEW, Volume 3, Issue 6, December 2022., 2022
The pandemic respiratory disease COVID‐19 has spread over the globe within a small span of time. Generally, there are two important points are being highlighted and considered towards the successful diagnosis and treatment process. The first point includes the reduction of the rate of infections and the next one is the decrease of the death rate.
Sudheesh K. Shukla, Santanu Patra, Trupti R. Das, Dharmesh Kumar, Anshuman Mishra, Ashutosh Tiwari   +5 more
wiley   +1 more source